Current Pharmaco-therapeutic Approach on COVID-19 Admitted Patients in a Corona-dedicated Hospital in Khulna

Authors

  • Baishakhi Islam Associate Professor & Head, Department of Pharmacology & Therapeutics, Gazi Medical College, Khulna, Bangladesh.
  • Syed Didarul Haque Associate Professor, Department of Pharmacology & Therapeutics, Gazi Medical College, Khulna, Bangladesh.

DOI:

https://doi.org/10.3329/mediscope.v11i1.71638

Keywords:

Pharmacotherapy, Supportive drugs, COVID-19

Abstract

Background: The COVID-19 pandemic has been demanding possible pharmaco-therapeutic options to reduce the mortality associated with the disease by trying out the clinical efficacy of various therapeutic agents. Objective: Our purpose of the study was to explore the current pharmaco-therapeutic approaches to COVID-19 patients in different clinical categories. Methods: This is a descriptive observational study where 300 clinically diagnosed COVID-19-positive patients were included following inclusion & exclusion criteria at the study center. Patients’ demographic profiles and treatment plans were obtained using a specially designed form. The data were collated and analyzed using a Microsoft Excel spreadsheet and results were expressed in percentages. Results: Remdesivir, moxifloxacin, dexamethasone, meropenem, enoxaparin and other supportive drugs with different percentages in mild, moderate, severe & critical cases were frequently prescribed. Besides non-invasive oxygen therapy has been given in almost all patients. Conclusion: Antiviral, LMWH, broad-spectrum antibiotics, corticosteroids and other symptomatic drugs are the major treatment options for different clinical categories of COVID-19 patients.

Mediscope 2024;11(1): 13-21

Downloads

Download data is not yet available.
Abstract
4
PDF
2

Downloads

Published

2024-03-19

How to Cite

Baishakhi Islam, & Syed Didarul Haque. (2024). Current Pharmaco-therapeutic Approach on COVID-19 Admitted Patients in a Corona-dedicated Hospital in Khulna. Mediscope, 11(1), 13–21. https://doi.org/10.3329/mediscope.v11i1.71638

Issue

Vol. 11 No. 1 (2024)

Section

Original Articles

License

Copyright (c) 2024 Baishakhi Islam, Syed Didarul Haque

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Mediscope agree to the following terms that:

  1. Authors retain copyright and grant Mediscope the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Mediscope are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  1. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  2. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.